[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354310-105":59,"doc-detail-354310-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","unraveling-let-7f-in-oncology-a-tumor-suppressor-with-emerging-clinical-significance","Unraveling Let-7f in oncology: a tumor suppressor with emerging clinical significance","","Unraveling Let-7f in oncology reviews how the microRNA let-7f is dysregulated across major malignancies and how its expression patterns relate to tumor size, stage, metastasis, and patient prognosis. It details upstream regulation by transcription factors, RNA-binding proteins, ceRNA networks, and genetic polymorphisms. The article explains let-7f’s tumor-suppressive roles in proliferation, invasion, metastasis, stemness, metabolic reprogramming, and tumor microenvironment modulation, and highlights its diagnostic and therapeutic promise.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/unraveling-let-7f-in-oncology-a-tumor-suppressor-with-emerging-clinical-significance/354310/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/unraveling-let-7f-in-oncology-a-tumor-suppressor-with-emerging-clinical-significance/354310.png","ImageObject",300,407,{"name":92,"@type":93},"Mimi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does let-7f play in cancer biology according to the review?","Question",{"text":112,"@type":113},"Let-7f functions as a tumor suppressor by inhibiting proliferation, invasion, metastasis, stemness maintenance, and metabolic reprogramming, largely through targeting multiple oncogenes and signaling pathways.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is let-7f expression regulated in tumors?",{"text":117,"@type":113},"The review describes regulation via transcription factors (such as C/EBPβ), RNA-binding proteins (such as LIN28), ceRNA networks (such as FAM222A-AS1 and LINC00106), and genetic polymorphisms.",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical uses of let-7f are discussed?",{"text":121,"@type":113},"Let-7f is presented as a predictive biomarker for chemotherapy, radiotherapy, and endocrine therapy efficacy, and as a non-invasive diagnostic marker using stable detection in body fluids like plasma and stool.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354310,1791323620,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","OPEN ACCESS  \nEDITED BY  \nChen Xue,  \nZhejiang University, China  \nREVIEWED BY  \nFloria Lizarraga,  \nNational Institute of Genomic Medicine (INMEGEN), Mexico  \nTabea Gewalt,  \nUniversity Hospital of Cologne, Germany  \n*CORRESPONDENCE  \nYuanming Pan,  \n [peterfpan2020@mail.ccmu.edu.cn](peterfpan2020@mail.ccmu.edu.cn)[ ](peterfpan2020@mail.ccmu.edu.cn)Xiangsheng Zeng,  \n [zxsheng1991@163.com](zxsheng1991@163.com)  \n†These authors share first authorship  \nRECEIVED 08 March 2026  \nREVISED 26 April 2026  \nACCEPTED 04 May 2026  \nPUBLISHED 29 May 2026  \nCITATION  \nDeng J, Li D, Li Z, Pan Y and Zeng X (2026) Unraveling Let-7f in oncology: a tumor  \nsuppressor with emerging clinical significance.  \nFront. Cell Dev. Biol. 14:1825514 .  \ndoi: 10.3389/fcell.2026.1825514  \nCOPYRIGHT  \n© 2026 Deng, Li, Li, Pan and Zeng. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nTYPE Review  \nPUBLISHED 29 May 2026  \nDOI 10.3389/fcell.2026.1825514  \nUnraveling Let-7f in oncology: a tumor suppressor with emerging clinical significance  \nJianhua Deng 1†, Daosheng Li 1, Zhiqi Li 2, Yuanming Pan 2* and Xiangsheng Zeng 1*  \n1Department of Oncology, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang NO.1 People’s Hospital, Jiujiang, Jiangxi, China, 2Cancer Research Center, Beijing Chest Hospital, Capital Medical University, Tuberculosis and Thoracic Tumor Research Institute, Beijing, China  \nAs a major global health threat, tumors present significant clinical challenges due to their heterogeneity, metastatic potential, and therapy resistance. In recent years, non-coding RNAs, particularly microRNAs (miRNAs), have emerged as crucial players in cancer research. Among them, let-7f, a key member of the let-7 family, exhibits significant dysregulation and biological functions in various cancers. This review systematically summarizes the differential expression patterns of let-7f in common malignancies, revealing its prevalent downregulation in cancers such as lung, gastric, colorectal, breast, and glioblastoma. This downregulation is closely associated with tumor size, stage, metastatic potential, and patient prognosis. The expression of let-7f is regulated by multiple molecular mechanisms, including transcription factors (e.g., C/EBPβ), RNA-binding proteins (e.g., LIN28), ceRNA networks (e.g., FAM222A-AS1, LINC00106), and genetic polymorphisms. Regarding biological functions, let-7f inhibits tumor cell proliferation, invasion, metastasis, stemness maintenance, and metabolic reprogramming by targeting multiple oncogenes (e.g., MYH9, HMGA2, ADAMTS1, Periostin) and key signaling pathways (e.g., MAPK, Wnt, PI3K/AKT) . Furthermore, let-7f is involved in modulating the tumor microenvironment, including angiogenesis, stromal cell function, and the immune milieu. At the therapeutic level, let-7f not only serves as a predictive biomarker for the efficacy of chemotherapy, radiotherapy, and endocrine therapy but also holds potential for reversing drug resistance and enhancing drug sensitivity. For diagnosis, its stable presence in body fluids like plasma and stool offers a non-invasive detection advantage, positioning it as a promising novel biomarker for various cancers. However, challenges remain, including the standardization of detection methods, optimization of delivery systems, and insufficient clinical validation. Future efforts should integrate multi-omics analyses, artificial intelligence-assisted modeling, and novel nanodelivery technologies to advance the translation of let-7f from basic research to clinical application, thereby providing new strategies for the pr","cbCairjSgDvEgync","https://ap.wps.com/l/cbCairjSgDvEgync","pdf",4357405,"English","# 1 Introduction\n## 1.1 Background and current status of cancer research","[{\"question\":\"What role does let-7f play in cancer biology according to the review?\",\"answer\":\"Let-7f functions as a tumor suppressor by inhibiting proliferation, invasion, metastasis, stemness maintenance, and metabolic reprogramming, largely through targeting multiple oncogenes and signaling pathways.\"},{\"question\":\"How is let-7f expression regulated in tumors?\",\"answer\":\"The review describes regulation via transcription factors (such as C/EBPβ), RNA-binding proteins (such as LIN28), ceRNA networks (such as FAM222A-AS1 and LINC00106), and genetic polymorphisms.\"},{\"question\":\"What clinical uses of let-7f are discussed?\",\"answer\":\"Let-7f is presented as a predictive biomarker for chemotherapy, radiotherapy, and endocrine therapy efficacy, and as a non-invasive diagnostic marker using stable detection in body fluids like plasma and stool.\"}]","Unraveling Let-7f in oncology: a tumor suppressor with emerging clinical significance | PDF",1790110010,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/371c53f0218d00a7e207df14ca7fbee5.webp",983,1390,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c50e0a8cf5d01d72773869aa3202d09.webp",982,1388,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f5918cd15ad46e957c8de9186bf5405.webp",981,1387,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78595d6f38f950f19213ec41bc8bc82e.webp",980,1385]